Clinical Trials Browser

Phase 2 × Endometrial Neoplasms × niraparib × Clear all

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Urologic Neoplasms, Endometrial Neoplasms

NCT04080284 2025-08-19

Trial of Maintenance With Niraparib- Uterine Serous Carcinoma

Phase 2 Completed

22 enrolled

Gynecologic

Uterine Neoplasms, Endometrial Neoplasms

NCT05523440 2025-03-28

Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation

Phase 2 Terminated

7 enrolled

Gynecologic

Ovarian Neoplasms, Endometrial Neoplasms

NCT03016338 2024-01-30

Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer

Phase 2 Unknown

51 enrolled

Gynecologic

Endometrial Neoplasms

NCT04716686 2024-01-05

Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma

Phase 2 Recruiting

83 enrolled

Gynecologic

Endometrial Neoplasms, Cystadenocarcinoma, Serous

Clinical Trials

PAVO

Trial of Maintenance With Niraparib- Uterine Serous Carcinoma

Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation

Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer

Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma